Ledger.Open graph →
SEC Form D · filed April 4, 2022

Lung Therapeutics, Inc

Offering
$15.0M
Sold
$10.1M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Austin, TX
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (8)

Aaron G. Fletcher · Austin, TXDirectorCharles C. Garner · Austin, TXExecWilliam C. Fairey · Austin, TXDirectorBrian Windsor · Austin, TXExec · DirectorCharles C. Garner · Austin, TXExecAaron G. Fletcher · Austin, TXDirectorWilliam C. Fairey · Austin, TXDirectorBrian Windsor · Austin, TXExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗